ARVIDAL

Dead / Abandoned — Abandoned — after inter partes decision (as of 14 Mar 2022)

What this means for you

This application is over — abandoned 14 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
79307220
Mark type
Word mark
Filed
11 Dec 2020
Published for opposition
02 Nov 2021
Abandoned
14 Mar 2022
Attorney of record
MATTHEW A HOMYK

Goods and services

  • Class 005 — Pharmaceuticals: pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections

Owner

Prosecution history

  • 05 Apr 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 14 Mar 2023 — FINAL DISPOSITION NOTICE SENT TO IB
  • 14 Mar 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 31 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 12 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 12 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 15 Mar 2022 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
  • 14 Mar 2022 — ABANDONMENT - AFTER INTER PARTES DECISION
  • 14 Mar 2022 — OPPOSITION TERMINATED NO. 999999
  • 14 Mar 2022 — OPPOSITION SUSTAINED NO. 999999
  • 13 Dec 2021 — REFUSAL PROCESSED BY IB
  • 22 Nov 2021 — OPPOSITION INSTITUTED NO. 999999
  • 16 Nov 2021 — OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
  • 16 Nov 2021 — OPPOSITION NOTICE (IB REFUSAL) CREATED
  • 15 Nov 2021 — OPPOSITION PAPERS RECEIVED AT TTAB

View this trademark record on Marksy